Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study
Nutrients · 28.02.2025 · 17 (5) · 844
DOI: 10.3390/nu17050844 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 28.02.2025. Verfasst von Xinyi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science and Nutritional Engineering, China Agricultural University, B…. Hauptthemen laut MEDLINE: Reishi, Triglycerides, Dyslipidemias, Spores, Fungal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, China Agricultural University-Sichuan Advanced Agricultural & Industrial Institute.
Abstract (Originalsprache)
Background
Ganoderma lucidum spore oil (GLSO) is widely recognized for its notable medicinal and nutritional properties. This study aimed to systematically evaluate the efficacy and safety of GLSO extract in individuals with dyslipidemia.
Methods
In a randomized, double-blind, placebo-controlled trial, 110 participants were enrolled and randomly assigned to either the intervention group or the placebo group. A chi-square test of baseline characteristics confirmed no significant differences in age or sex distribution between the two groups.
Results
After 12 weeks of intervention, the intervention group exhibited significantly lower levels of total cholesterol (CHO), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), alongside significantly higher levels of high-density lipoprotein cholesterol (HDL-C), compared to the placebo group, with all differences reaching statistical significance. Furthermore, the relative percentage changes in lipid parameters also demonstrated significant intergroup differences. Safety analyses revealed that the intervention had no notable effects on renal function parameters, whereas hepatic function parameters showed statistically significant improvement in the intervention group.
Conclusions
This study demonstrated that GLSO extract effectively improved lipid profiles and liver function, with a favorable safety and tolerability profile. These findings strongly support the potential clinical application of GLSO extract in the management of dyslipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
- Capital Healthcare and Nutrition Cuisine Society, Beijing 100082, China.
- Key Laboratory of Geriatric Nutrition and Health, Beijing Technology and Business University, Ministry of Education, Beijing 100048, China.
- China Agricultura University-Sichuan Advanced Agricultural & Industrial Institute, China Agricultural University, Chengdu 611430, China.
ORCID-Profile: Liang Zhao, Feng Zhou
Förderung
- National Key Research and Development Program of China
- China Agricultural University-Sichuan Advanced Agricultural & Industrial Institute
Zitieren
APA
Wang, X., Wang, X., Zhao, L., & Zhou, F. (2025). Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study. Nutrients, 17(5), 844. https://doi.org/10.3390/nu17050844
Vancouver
Wang X, Wang X, Zhao L, Zhou F. Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study. Nutrients. 2025;17(5):844. doi:10.3390/nu17050844
BibTeX
@article{Wang2025,
author = {Wang, Xinyi and Wang, Xufeng and Zhao, Liang and Zhou, Feng},
title = {Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {5},
pages = {844},
doi = {10.3390/nu17050844}
}
EUVIMED